ArticleMolecular diversity2026
Dendrobium officinale Kimura et Migo regulates the proliferation and migration of colon adenocarcinoma via LGALS4.
Article in Molecular diversity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Dendrobium officinale Kimura et Migo (DO) has demonstrated potential anti-colon adenocarcinoma (COAD) effects; however, its underlying mechanisms of action require further elucidation. In this study, DO (work concentrations of 0, 0.1, and 0.01 μg/mL) was administered to HCT116 and Caco-2 cells to evaluated cell viability and migration. Herb databases were utilized to identify potential DO targets. Differential gene screening and weighted gene co-expression network analysis were conducted on the GSE35782 dataset, followed by enrichment analysis and immune infiltration analysis. Key genes were validated using The Cancer Genome Atlas (TCGA), molecular docking, and real-time polymerase chain reaction. The study found that DO significantly inhibited the viability and migration of HCT116 or Caco-2 cells (P < 0.05). A total of 26 key genes were identified, among which galectin-4 (LGALS4) was significantly downregulated in TCGA-COAD (P < 0.05) and was correlated with prognosis (P < 0.05). Molecular docking revealed that the binding energy between LGALS4 and lactose, dendronobiloside A, and dendronobiloside B was-7.22,-9.05, and-8.05 kcal/mol, respectively, forming 5, 11, and 8 hydrogen bonds. Overall, DO effectively suppresses the viability and migration of COAD HCT116 or Caco-2 cells, with LGALS4 potentially serving as a key target.
Indexed as
Identifiers
40911261What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.